Methylprednisolone Acetate Injection
Amneal Pharmaceuticals · Limited Availability · Reason: Other
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 12/15/2021
- Package NDC
- 70121-1573-1
- Generic name
- Methylprednisolone Acetate Injection
- Contact info
- 866-525-7270
- Availability
- Limited Availability
- Related info
- On backorder. Estimated recovery: late July
- Update date
- 06/17/2026
- Dosage form
- Injection
- Presentation
- Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)
- Company name
- Amneal Pharmaceuticals
- Shortage reason
- Other
- Status
- Current
- Therapeutic category
- Rheumatology
- Harmonized identifiers (openFDA)
- Application number
- ANDA210043
- Brand name
- METHYLPREDNISOLONE ACETATE
- Generic name
- METHYLPREDNISOLONE ACETATE
- Manufacturer name
- Amneal Pharmaceuticals LLC
- Product NDC
- 70121-1573, 70121-1574
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRASYNOVIAL, SOFT TISSUE
- Substance name
- METHYLPREDNISOLONE ACETATE
- RxCUI
- 1743779, 1743855
- SPL ID
- af4215ff-94ca-44f8-8506-3024e738cd13
- SPL set ID
- d944240d-2c19-46ba-ad4f-3fbee7b8629c
- Package NDC
- 70121-1573-1, 70121-1573-5, 70121-1574-1, 70121-1574-5
- UNII
- 43502P7F0P